Factors Associated with use of Sexual Enhancers and Erectile Dysfunction Medications among Male Undergraduates Aged 18-35yrs at Jomo Kenyatta University of Agriculture and Technology, Kenya
erectile dysfunction medications and sexual enhancers have increasingly been used
among young men without a medical indication. Recreational use of erectile
dysfunction medication (EDMs) and sexual enhancers is associated with risky
sexual behaviour and substance use. In recognition of the sexual health
challenges facing the youth, this study sought to establish the level of
utilization of sexual enhancers and EDMs and factors associated with their use
among the male undergraduates at Jomo Kenyatta University of Agriculture and
Methods: A concurrent nested design was used.
It adopted a cross-sectional quantitative study design (through
self-administered questionnaires) and a concurrent qualitative study (through
Focus Group Discussions). Simple random sampling was used to obtain the required
study participants for quantitative data (420 respondents) and convenience
sampling for the qualitative data (48 respondents).
Results: Among the 420 respondents (aged 21.7 ±2.03years),
82.9% (n=348) had heard about EDMs and/or sexual enhancers but only 10 % (n=42)
had used them. There was a significant relationship between EDMs and/or sexual
enhancers use and age (P<0.001), religion (P=0.013), number of sexual
partners (P=0.027), number of ‘one-night’ stands (P=0.003), and use of condom
or knowledge of partner’s status before intercourse (P=0.011).
Conclusion: The prevalence of EDMs and/or sexual enhancers’ use among the
students was 10%. Risky sexual behaviour and substance abuse including alcohol
consumption was associated with EDMs and/or sexual enhancers’ use. The
university social environment influenced sexual risk behaviour. Continuous awareness
campaigns aimed at educating undergraduate students about the risks involved in
the recreational use of EDMs and/or sexual enhancers should be done.
S., Ahmed, A. F., Gabr, A. H., Al Ansari, A., El-feky, M., & Elbadry, M. S.
(2016). Phosphodiesterase type 5 inhibitors: Irrational use in Saudi Arabia. Arab
journal of urology, 14(2), 94-100.
A., Casabé, A., De Bonis, W., Helien, A., & Bertolino, M. V. (2010). Recreational
use of phosphodiesterase type 5 inhibitors by healthy young men. The journal of
sexual medicine, 7(11), 3736-3742.
E., Mar-Tang, M., & Mathews, W. (2004). Screening for Potentially Transmitting
Sexual Risk Behaviors, Urethral Sexually Transmitted Infection, and Sildenafil use
among Males entering Care for HIV infection. AIDS Patient Care and STDs, 18, 349–354.
N., Clark, J. P., Stecher, V. J., Thomas, J. W., Callanan, A. C., Donnelly, B. F.,
... & Kaminetsky, J. C. (2013). Adulteration of Purported Herbal and Natural
Sexual Performance Enhancement Dietary Supplements with Synthetic Phosphodiesterase
type 5 Inhibitors. The journal of sexual medicine, 10(7), 1842-1849.
E., O’Cathain, A., Goyder, E. C., & Freeman, J. V. (2014). Factors perceived
to influence risky sexual behaviours among university students in the United Kingdom:
a qualitative telephone interview study. BMC public health, 14(1), 1055.
G., Mansergh, G., Guzman, R., Vittinghoff, E., Marks, G., Rader, M., et al. (2001).
Drug use and sexual risk behavior among gay and bisexual men who attend circuit
parties: A venue-based comparison. Journal of Acquired Immune Deﬁciency Syndromes,
M., Rodger, A., Phillips, A. N., Sherr, L., Speakman, A., Collins, S., ... &
Wilkins, E. (2014). Recreational drug use, polydrug use, and sexual behaviour in
HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional
ASTRA study. The Lancet HIV, 1(1), e22-e31.
D. G., Malow, R., Rosenberg, R., Reynolds, G. L., Farrell, N., & Jaffe, A. (2006).
Recreational Viagra use and sexual risk among drug abusing men. American Journal
of Infectious Diseases, 2(2), 107-114.
V. M. D., Menezes, F. G. D., Antonialli, M. M. S., & Nascimento, J. W. L. (2008).
Freqüência de uso de inibidores de fosfodiesterase-5 por estudantes universitários.
Revista de Saúde Pública, 42(5), 965-967.
I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P.
A. (1998). Oral sildenafil in the Treatment of Erectile Dysfunction. New England Journal of Medicine, 338, 1397–1404.
N., Zurita, B., Velasco, C., Feliu, A., Gutierrez, M., Masip, M., & Mangues,
M. A. (2017). Prevalence and clinical impact of recreational drug consumption in
people living with HIV on treatment: a cross-sectional study. BMJ open, 7(1), 1-10.
E. A., Bhagavathula, A. S., Gebresillassie, B. M., Tefera, Y. G., Belachew, S. A.,
& Erku, D. A. (2016). Recreational Use of Phosphodiesterase 5 Inhibitors and
Its Associated Factors among Undergraduate Male Students in an Ethiopian University:
A Cross-Sectional Study. The World Journal of Men's Health, 34(3), 186-193.
N., (2013, June 12). “‘Lipido epidemic’ threat as women force men into sex drugs.”
Standard Media. Retrieved from https://www.standardmedia.co.ke/article/2000088190/libido-epidemic-threat-as-women-force-men-into-sex-drugs
I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P.
A. (1998). Oral sildenafil in the Treatment of Erectile Dysfunction. New England
Journal of Medicine, 338, 1397–1404.
I., Meilinger, M., Schalk, H., Leichsenring, B., & Dorner, T. E. (2018). Prevalence
and Associations of Illicit Drug and Polydrug Use in People Living with HIV in Vienna.
Scientific reports, 8(1), 8046.
C. B., & Meston, C. M. (2011). Recreational Use of Erectile Dysfunction Medications
in Undergraduate Men in the United States: Characteristics and Associated Risk Factors.
Archives of sexual behavior, 40(3), 597-606.
C. B., & Meston, C. M. (2012). Recreational Use of Erectile Dysfunction medications
and its adverse effects on erectile function in young healthy men: the mediating
role of confidence in erectile ability. The journal of sexual medicine, 9(7), 1852-1859.
A. A., Kent, C. K., & Klausner, J. D. (2002). Increased Risk of HIV and Sexually
Transmitted Disease Transmission among Gay or Bisexual Men who use Viagra, San Francisco
2000–2001. AIDS, 16, 1425–1428.
B. A. N. (2014). Factors Associated with Condom Use among Students at Jomo Kenyatta
University of Agriculture and Technology (Doctoral dissertation).
F., Costa‐Matos, A., Gasperini, R., Reginato, P.
V., & Perez, M. D. (2008). Recreational use of PDE5 inhibitors by young healthy
men: Recognizing this issue among medical students. The journal of sexual medicine,
J., McCambridge, J., Mitcheson, L., Hunt, N., & Winstock, A. (2006). The rise
of Viagra among British illicit drug users: 5-year survey data. Drug and alcohol
review, 25(2), 111-113.
N. S., Hartrich, M., & Garofalo, R. (2006). Erectile Dysfunction and Viagra
Use: What’s up with college-age males? Journal of Adolescent Health, 39, 452–454.
D. W., Bimbi, D. S., & Parsons, J. T. (2008). Motivations for the recreational
use of erectile enhancing medications in urban gay and bisexual men. Sexually transmitted
infections, 84(6), 458-462.
Inc. Viagra Web site. Retrieved from at http://www.viagra.com/content/viagra-sample-pack.jsp?setShowOn=../content/getting-viagra prescription.jsp&setShowHighlightOn=/content/viagra-sample-pack.jsp.
Accessed on February 22, 2017.
G., Jin, F., Kippax, S., Zablotska, I., Imrie, J., & Grulich, A. (2009). Use
of illicit drugs and erectile dysfunction medications and subsequent HIV infection
among gay men in Sydney, Australia. The journal of sexual medicine, 6(8), 2311-2320.
(2015, Oct 18). Why Are So many Men Misusing Erectile Dysfunction Drugs? Prostate.net.
Retrieved from http://prostate.net/articles/why-are-so-many-men-misusing-erectile-dysfunction-drugs
R. C., & Kostis, J. B. (2003). Overview of Phosphodiesterase 5 Inhibition in
Erectile Dysfunction. American Journal of Cardiology, 92 (Suppl. 9A), 9M–15M.
P., Sandnabba, N. K., Jern, P., Varjonen, M., Witting, K., & Von Der Pahlen,
B. (2007). Recreational use of erectile dysfunction medication may decrease confidence
in ability to gain and hold erections in young males. International journal of impotence
research, 19(6), 591-596.
L., Bolding, G., Maguire, M., & Elford, J. (2000). Viagra use and sexual risk
behavior among gay men in London. AIDS, 14, 2051–2053.
K. M., & Romanelli, F. (2005). Recreational use and misuse of phosphodiesterase
5 inhibitors. Journal of the American Pharmacists Association, 45(1), 63-75.
S. G., & Klausner, J. D. (2005). Sildenafil Use, Sexual Risk Behavior, and Risk
for Sexually Transmitted Diseases, including HIV Infection. American Journal of
Medicine, 118, 571–577.